PharmaShots

FEBRUARY 21, 2023

threshold by 2026. This year, Novartis has secured the top position with a market cap of $207.65B, followed by Bayer and Lantheus Medical Imaging PharmaShots has compiled a list of the Top 20 Radiopharma Companies developing products as a treatment option, ranked based on their market cap.

Dosage 56

Dosage Labelling Immunity Immunization 56

STAT

DECEMBER 10, 2024

  Democrats floated the idea of extending the subsidies through 2026 in a year-end deal, and paying for it with a budgetary maneuver that would theoretically extend budget cuts that haven’t actually been implemented, as my colleague Rachel Cohrs Zhang reported. million people would lose coverage annually without the tax credits. 

Drug Pricing 258

Drug Pricing Drug Development Vaccines 258

Safe Biologics

SEPTEMBER 11, 2023

A Better Reform: Ensuring Savings Are Passed Onto Patients While price-setting proponents say beneficiaries will start to see lower drug prices beginning in 2026, there’s no evidence that this is true, and there are better ways to lower out-of-pocket costs- and much faster, Reilly explains.

Drug Pricing 150

Drug Pricing Biosimilars Vaccines Drug Development 150

Viseven

SEPTEMBER 18, 2024

When COVID hit, the urgent need to accelerate drug development meant shrinking timelines from years to months, with no room for compromises on quality. The rest is history: vaccines were delivered worldwide in record time, saving millions of lives. By the end of 2026, the company will be able to analyze two million genomes.

Communication 52

Communication Vaccines Pharmaceutical Companies Pharmaceutical Companies 52